Startups

AcousticaBio logo

AcousticaBio

AcousticaBio is a Harvard spinout founded in 2022 developing acoustic fluid-processing technology for advanced biologic drug manufacturing. Its platform forms concentrated microparticle formulations intended to enable smaller-volume subcutaneous delivery of therapies otherwise administered intravenously.

Team

Anjali KumarStrategic Advisor
Daniele ForestiFounder and CEO
Devan YarberryResearch Associate
Filippo CampanelliHardware Engineering Intern
Glen BoltonBioprocessing Advisor
Janani NandakumarResearch Associate Intern
Jennifer LewisScientific Co-Founder
Kristen WekSenior Scientist
Manish TiwariScientific Advisor
Marcello DamianiStrategic Advisor
Mark Skylar-ScottScientific Advisor
Matthew GothardSenior Mechatronics Engineer
Mike HagerDirector of Finance and Operations

Investments